Cited by 422MicroRNA in disease regulationCancer-related molecular mechanisms researchPlant Molecular Biology Research

Interplay between miRNAs and human diseases

Paul, Prosenjit, Chakraborty, Anindya, Sarkar, Debasree, Langthasa, Malobika, Rahman, Musfhia, Bari, Minakshi, Singha, RK. Sanamacha, Malakar, Arup Kumar +1 more·2018·Journal of Cellular Physiology

Abstract

MicroRNAs (miRNAs) are endogenous, non-coding RNAs, which have evoked a great deal of interest due to their importance in many aspects of homeostasis and diseases. MicroRNAs are stable and are essential components of gene regulatory networks. They play a crucial role in healthy individuals and their dysregulations have also been implicated in a wide range of diseases, including diabetes, cardiovascular disease, kidney disease, and cancer. This review summarized the current understanding of interactions between miRNAs and different diseases and their role in disease diagnosis and therapy.

Integrity signals

Registry

Crossref · 10.1002/jcp.25854

Cites

170 of 170 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

3 retracted

Flagged first, then by citations

2 of the 172 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S.
Affiliations
Assam University (IN)
Corresponding author
Chakraborty, Supriyo
Venue
Journal of Cellular Physiology
Publisher
Wiley
Published
2017-04-27
Volume
233
Issue
3
Pages
2007-2018
ISSN
  • 0021-9541 (ISSN-L)
  • 1097-4652
OpenAlex
W2586411032
Cited by
420
References
172
Citations by year
2026: 9 · 2025: 36 · 2024: 44 · 2023: 44 · 2022: 61 · 2021: 64 · 2020: 69 · 2019: 53 · 2018: 24 · 2017: 16
FWCI
4.54
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cellular Physiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Assam University, Silchar
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
Keywords
microRNA, non-coding RNA, gene regulatory networks, pathogenesis, diabetes mellitus, cardiovascular disease, kidney disease, cancer, disease diagnosis, therapeutic target
MeSH terms
Diabetes Mellitus, Humans, Kidney Diseases, Cardiomyopathies, Neoplasms, MicroRNAs, Atherosclerosis, Gene Regulatory Networks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review